Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - What's Next?

Key Points

• Ascentage Pharma Group International's stock price increased significantly, opening at $39.79 after a previous close of $37.80, indicating strong market interest.
• The company recently attracted institutional investment, with Monashee Investment Management LLC buying approximately 159,942 shares valued at around $3.5 million.
• Ascentage Pharma is a clinical-stage biotechnology company focused on developing therapies for cancers, hepatitis B, and age-related diseases.

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - )'s stock price gapped up before the market opened on Monday . The stock had previously closed at $37.80, but opened at $39.79. Ascentage Pharma Group International shares last traded at $39.55, with a volume of 6,561 shares.

Ascentage Pharma Group International Stock Performance

The business has a fifty day moving average of $34.12. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 3.24.

Institutional Trading of Ascentage Pharma Group International

An institutional investor recently bought a new position in Ascentage Pharma Group International stock. Monashee Investment Management LLC purchased a new stake in Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 159,942 shares of the company's stock, valued at approximately $3,511,000. Monashee Investment Management LLC owned approximately 0.18% of Ascentage Pharma Group International at the end of the most recent quarter.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.